HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,169-6,180 of 27,277
Drug study icon
CompletedNCT00143182

9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)

Official study title

A Double-Blind, 9-Week Extension Study Evaluating the Safety and Maintenance of Effect of Asenapine vs. Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501006 (Secondary Title: ARES)

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 18+
Countries
Sponsor
Organon and Co
Behavioral study icon
CompletedACTRN12615000480583

A ‘open study’ evaluation study of the LIFE FLeX eHealth wellbeing program for anxiety and depression.

Official study title

A open study evaluation trial of the LIFE FLeX eHealth wellbeing program for reducing anxiety and depression and increasing emotional regulation and positive affect in adults with depression and anxiety.

This study has finished and is no longer accepting participants.

In Australia
Depression, AnxietyInterventional studyAges 18+
Countries
Australia
Sponsor
Federation University
Behavioral study icon
CompletedACTRN12617000901303

A 12 week study targeted for adult consumers within a community mental health rehabilitation setting to implement a Personal Safety Tool for self-management and crisis management.

Official study title

A pilot study on the use of a Personal Safety Tool for self-management and crisis management within a clinical mental health rehabilitation setting.

This study has finished and is no longer accepting participants.

In Elizabeth Vale
Personality disorders, Dissociative disorders, ...Interventional studyAges 18–65
Countries
Australia
Sponsor
Michelle Oliver
Other study type icon
TerminatedNCT04742413

A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in people with Schizophrenia. RESPECT Study.

Official study title

A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.

This study ended early.

Multiple locations, including Málaga
SchizophreniaObservational studyAges 18+
Countries
Spain
Sponsor
Angelini Farmacéutica
Drug study icon
CompletedEUCTR 2007-005959-42

A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolarity type I Pat...

Official study title

A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolar I Disorder Pat...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
BipolarityHistorical research record
Countries
France, Austria, Czechia, + 6 others
Sponsor
Bristol Myers Squibb International Corporation
Drug study icon
CompletedEUCTR 2012-003805-86

A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Latvia
SchizophreniaHistorical research record
Countries
Latvia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.